About US
Contact us
-
AbbVie takes some heat for raising price of Niaspan after studies panned itWhen studies ofAbbVie'schloesterol drug Niaspan raised questions about its effectiveness, analysts suggested it would lose its blockbuster status. But in the face of falling sales, AbbVie'sformer par2013/5/27
-
Billionaires snap up former Merck Serono HQ for Geneva biotech hotspotTwo Swiss billionaires--Ernesto Bertarelli and Hansjörg Wyss--have joined forces to buy out the former Merck Serono facility in Geneva, with ambitious plans to create a major collaboration on di2013/5/23
-
CFDA issues The Second Drug Quality Announcement of 2013China Food and Drug Administration (CFDA) issued on May 16, 2013 the Second Drug Quality Announcement of 2013, and released the quality sampling and testing results of 11 national essential drugs and2013/5/23
-
Impax calls on former Teva, Watson execs to confront FDA issuesHaving failed so far to get its extended-release Parkinson's drug Rytary to market, Impax Laboratories ($IPXL) is turning to asking three big-name specialists what it should do. The Hayward, CA dru2013/5/22
-
Vermont passes assisted-suicide law, with drug-dispensing safeguardsVermont officially became the fourth state to allow physician-assisted suicide. The law includes safeguards, including requirements that terminally ill patients ask for the requisite drugs three time2013/5/22
-
GlaxoSmithKline, Ranbaxy among hardest hit in Indian price cutsIndia's skeptical patent regime is only one of pharma's worries in the country. New price controls are on their way, and brokerage house HSBC has identified which companies are most likely to suffer2013/5/21
-
Ex-HGS director draws fire for plugging anthrax drug at PentagonDid Human Genome Sciences unfairly benefit from its political connections? According to a Los Angeles Times investigation, former Navy Secretary Richard Danzig talked up HGS' anthrax drug raxibacumab2013/5/21
-
Australian judge kills Merck Vioxx class action settlementA federal judge in Australia has put the kibosh on a half-million-dollar settlement over ill effects of Merck's ($MRK) painkiller Vioxx, a drug that has spawned billions of dollars in litigation. Just2013/5/20
-
CFDA issues announcement on implementation of electronic supervision for drugs in the National Essential Medicine List (2012 edition)On May 9, 2013, China Food and Drug Administration (CFDA) issued an Announcement on implementation of electronic supervision for drugs in the National Essential Medicine List (2012 edition).2013/5/20
-
WSJ: Novartis said to eye $16B offer for ActavisActavis ($ACT) has suddenly become the belle of the ball. The Wall Street Journal reports that deal talk is heating up, with Novartis ($NVS) said to be entertaining a $16 billion bid for the generics2013/5/17